KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Share-based Compensation (2016 - 2025)

Thermo Fisher Scientific's Share-based Compensation history spans 17 years, with the latest figure at $84.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Share-based Compensation rose 6.33% year-over-year to $84.0 million, compared with a TTM value of $310.0 million through Dec 2025, up 2.99%, and an annual FY2025 reading of $310.0 million, up 2.99% over the prior year.
  • Share-based Compensation for Q4 2025 was $84.0 million at Thermo Fisher Scientific, up from $70.0 million in the prior quarter.
  • The five-year high for Share-based Compensation was $84.0 million in Q2 2024, with the low at $51.0 million in Q2 2021.
  • Average Share-based Compensation over 5 years is $71.3 million, with a median of $75.0 million recorded in 2022.
  • Year-over-year, Share-based Compensation skyrocketed 52.94% in 2022 and then dropped 18.67% in 2023.
  • Tracing TMO's Share-based Compensation over 5 years: stood at $77.0 million in 2021, then decreased by 2.6% to $75.0 million in 2022, then dropped by 18.67% to $61.0 million in 2023, then rose by 29.51% to $79.0 million in 2024, then grew by 6.33% to $84.0 million in 2025.
  • Per Business Quant, the three most recent readings for TMO's Share-based Compensation are $84.0 million (Q4 2025), $70.0 million (Q3 2025), and $81.0 million (Q2 2025).